Compounds > meglumine antimoniate
Page last updated: 2024-08-24

meglumine antimoniate and Shock, Septic

meglumine antimoniate has been researched along with Shock, Septic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbasi, I; Aguirre, C; Calvopina, M; Castillo, A; Cevallos, W; Warburg, A1
Hantson, P; Haufroid, V; Lambert, M; Luyasu, S1

Other Studies

2 other study(ies) available for meglumine antimoniate and Shock, Septic

ArticleYear
Coinfection of
    The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5

    Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Cytochromes b; Fatal Outcome; HIV; HIV Infections; Humans; Leishmania guyanensis; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Proteins; Sequence Analysis, DNA; Shock, Septic; Skin; Treatment Failure

2017
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.
    Pharmacotherapy, 2000, Volume: 20, Issue:9

    Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic

2000